AstraZeneca Takes Five: DTC Study Finds Five Risks Per Ad Is Optimal For Recall
• By The Pink Sheet
An AstraZeneca study on consumer communication through direct-to-consumer television advertisements identifies five risks as the optimal number to include in order to ensure consumer recall of safety information
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
